Method evidence record

Phase I Clinical Trial

A Phase I clinical trial is the first stage of human testing for a new drug, biologic, or intervention. Its primary objective is to evaluate safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) rather than therapeutic efficacy. Small cohorts of participants — typically healthy volunteers or patients with advanced disease — receive sequentially increasing doses to identify the maximum tolerated dose (MTD) and the dose-limiting toxicities (DLTs) that define the boundary for subsequent trials.

Sources recorded, not reviewed

Source record

Citations copied verbatim from the method’s source record. No claim-level verification is inferred from them.

Phase I Clinical Trial (First-in-Human / Dose-Escalation Study)

Taxonomic method record · process-pipeline / epidemiology

Open full method

Curated claims

Claims persisted in the evidence ledger, each with its own assessment.

No curated claims yet

This view does not invent a claim assessment when the ledger has none.

Related methods

Generated from the method graph and shown as machine-suggested relations — no evidence claim is inferred.

Taxonomic bucketAdaptive Randomized Clinical Trialmachine-suggested · Relational suggestion, not evidence.Same method familyDiagnostic Accuracy Study Designmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketDose-Response Analysismachine-suggested · Relational suggestion, not evidence.Taxonomic bucketPhase II clinical trialmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketPhase III clinical trialmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketRandomized clinical trialmachine-suggested · Relational suggestion, not evidence.